This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Healthcare Contract Manufacturing Market over the forecast period. The global healthcare contract manufacturing market is expected to grow at a CAGR of 9.86% during the forecast period 2017–2023.
MarketResearchFuture.com adds “Healthcare Contract Manufacturing Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.
Contract manufacturing refers to a manufacturer who contracts with another company to make certain components or products over an equally agreed period. The healthcare contract manufacturing organization serves other companies in the medical devices and pharmaceutical industries to provide comprehensive services from drug development to drug manufacturing.
The global healthcare contract manufacturing market is majorly driven by factors such as patent protection expiration of major drugs and medical devices, and competition and economics of production and trade to favor CMO will boost the market growth. The global healthcare contract manufacturing market is expected to grow due to the increasing demand for drugs and medical devices because of the growing population, especially in emerging economies. The market around the globe is expanding especially in developing countries such as India and China. There is a major patent cliff occurring in the healthcare market worldwide, more specifically in the pharmaceutical industry. The patent cliff will result in cheaper generic versions in the market which in turn will increase the demand for CROs. The increased demand is expected to benefit the healthcare contract manufacturing industry. Due to patent expirations, it is assumed that the drug sales will face a loss of approximately 75 USD billion between 2016 and 2023. Roughly the drug sales of 60 USD billion of is expected to be threatened by generics. The off-patent drugs in 2016 were adalimumab, ledipasvir/sofosbuvir, rituximab, bevacizumab, and trastuzumab. Thus, patent protection expiration of major drugs and the growing demand for generic drugs are likely to boost the growth of CMOs globally.
However, supply chain complexity and issues of control of 3rd parties may hamper the market may affect the growth of the global healthcare contract manufacturing market negatively.
You can get easy access to sample report here, please click: https://www.marketresearchfuture.com/sample_request/5637 .
Some of key the players in the global healthcare contract manufacturings market are Patheon (Netherlands), Lonza (Switzerland), Evonik Industries (Germany), Teva Pharmaceutical Industries (Israel), Boehringer Ingelheim BioXcellence (Germany), Famar S.A. (Greece), Fareva Group (France), Vetter Pharma International (Germany), Mylan (U.S.), Recipharm (Sweden), Aesica Pharmaceuticals (U.K.), Althea Technologies (U.S.), Aenova (Germany), Dishman Pharmaceuticals and Chemicals Limited (India), Catalent Pharma Solutions (U.S.), Kemwell Pvt. Ltd. (India), Jubilant Life Sciences Limited (India), Nipro Corporation (Japan), NextPharma (UK), Pfizer Central Source (U.S.), Royal DSM N.V. (Netherlands), Abbott Laboratories (U.S.), Amgen (U.S.), Apotex (U.S.), Aspen (U.S.), AstraZeneca PLC (UK), Aurobindo Pharma (India), Baxter International (U.S.), BERLIN-CHEMIE (Germany), Biocon (India), Biogen (U.S.), Celltrion (South Korea), Cipla (India), Coherus Biosciences (U.S.), Daiichi Sankyo (Japan), Dr. Reddy’s Laboratories (India), Eli Lilly and Company (U.S.), Emcure Pharmaceuticals (India), Eurofarma Laboratories (Brazil), Gedeon Richter (Hungary), Gilead Sciences (U.S.), GlaxoSmithKline (GSK) Plc (U.S.), Hospira (U.S.), Impax Laboratories (U.S.), Intas Pharmaceuticals (India), Janssen Pharmaceuticals (U.S.), Lupin (India), Merck and Co. Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Natco Pharma (India), Nexus Pharmaceuticals (U.S.), Novo Nordisk (Denmark), Orchid Chemicals & Pharmaceuticals (India), Par Pharmaceutical (U.S.), Parenteral Drugs (India), Piramal (India), Roche Holding (Switerzland), Sanofi (France), Synthon (Netherlands), Teva Pharmaceuticals (Israel), Valeant Pharmaceuticals (Canada), Zentiva (Czech Republic), Zhejiang Huahai Pharmaceutical (China), Zydus Cadila (India), and others.
The global healthcare contract manufacturing market is segmented on the basis of product, industry, type, and services.
On the basis of the product, the global healthcare contract manufacturing market is segmented into active pharmaceutical ingredients (API), final dosage formulations (FDF), advanced drug delivery products, OTC medicines and nutritional products, and others. Moreover, the finished dosage formulations (FDF) is segmented into a tablet, capsules, oral liquids, parenteral/injectables, and others.
On the basis of the industry, the global healthcare contract manufacturing market is segmented into pharmaceutical, biopharmaceutical, and others.
On the basis of the type, the global healthcare contract manufacturing market is segmented into sterile, non-sterile, and others
On the basis of the service, the global healthcare contract manufacturing market is segmented into oncology research, vaccines research, inflammation & immunology research, cardiology research, neuroscience research, and others.
Any query or specific requirement? Ask to our industry expert, please click: https://www.marketresearchfuture.com/enquiry/5637 .
Global healthcare contract manufacturings consist of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas holds the largest share of the global healthcare contract manufacturing market owing to the rising number of drug approvals as one of the factors fuelling the growth. The patent expiries of blockbuster drugs are creating a new opportunity to vendors to develop biosimilars at low cost. Thus, the market is anticipated entry of biosimilars and generics, which is likely to further strengthen the growth in this region.
The European market dominated the global healthcare contract manufacturings market owing to the high prevalence rate of various disease in the Eastern European regions.
The Asia Pacific region is anticipated to be the fastest growing region over the forecast period owing to the increasingly favorable government initiatives along with the improving healthcare infrastructure.
What makes our report unique?
1) An extensive research study on the Global Healthcare Contract Manufacturing market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Healthcare Contract Manufacturing market.
2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.
…CONTINUED FOR TOC
Feel free to get in touch for discounts and customized details, please click: https://www.marketresearchfuture.com/check-discount/5637 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312